CannRelief CBD oils are the first product
among many to be launched as part of the skincare and cosmetic
product line
LEAMINGTON, ON, April 1, 2019 /CNW/ - Aphria Inc.
("Aphria" or the "Company") (TSX:
APHA and NYSE: APHA) through its subsidiary
Aphria Deutschland GmbH ("Aphria Germany") today launched
the Company's first CBD-based nutraceutical, the first product in
its CBD-based cosmetics line for the German market. Featuring CBD
derived from hemp, the CannRelief brand of products are being
produced in the European Union and distributed by the Company's
subsidiary, CC Pharma, which has access to more than 13,000
pharmacies throughout Germany.
"We are excited to introduce our first brand of CBD products for
the German nutraceutical and cosmetics market," said Jakob
Ripshtein, President of Aphria. "Supported by our extensive
distribution network through CC Pharma, CannRelief provides a
natural extension to Aphria's growing business opportunities in the
German medical cannabis market. We look forward to providing a full
range of CannRelief CBD products this year."
CannRelief CBD oils are being sold in both a 5% and 10% CBD
concentration and can be found in select stores across Germany. A range of skincare and other
products, including creams, serums and masks will be introduced
under the CannRelief brand in a phased rollout in 2019. More
information about CannRelief products can be found at
cannrelief.de.
"Aphria continues to execute on its strategic growth initiatives
in Germany," continued Ripshtein.
"We believe we have tremendous momentum in Germany and across our international business
as we continue to strengthen our global footprint."
We Have A Good Thing Growing
About Aphria
Aphria is a leading global cannabis company driven by an
unrelenting commitment to our people, product quality and
innovation. Headquartered in Leamington,
Ontario – the greenhouse capital of Canada – Aphria has been setting the standard
for the low-cost production of safe, clean and pure
pharmaceutical-grade cannabis at scale, grown in the most natural
conditions possible. Focusing on untapped opportunities and backed
by the latest technologies, Aphria is committed to bringing
breakthrough innovation to the global cannabis market. The
Company's portfolio of brands is grounded in expertly-researched
consumer insights designed to meet the needs of every consumer
segment. Rooted in our founders' multi-generational expertise in
commercial agriculture, Aphria drives sustainable long-term
shareholder value through a diversified approach to innovation,
strategic partnerships and global expansion, with a presence in
more than 10 countries across 5 continents.
For more information, visit: aphria.ca
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain
information in this news release constitutes forward-looking
statements under applicable securities laws. Any statements that
are contained in this news release that are not statements of
historical fact may be deemed to be forward-looking statements.
Forward looking statements are often identified by terms such as
"may", "should", "anticipate", "expect", "potential", "believe",
"intend" or the negative of these terms and similar expressions.
Forward-looking statements in this news release include, but are
not limited to, statements with respect to internal expectations,
estimated margins, expectations with respect to actual production
volumes, expectations for future growing capacity and costs, the
completion of any capital project or expansions, and expectations
with respect to future production costs. Forward-looking statements
necessarily involve known and unknown risks, including, without
limitation, risks associated with general economic conditions;
adverse industry events; marketing costs; loss of markets; future
legislative and regulatory developments involving cannabis;
inability to access sufficient capital from internal and external
sources, and/or inability to access sufficient capital on
favourable terms; the cannabis industry in Canada generally, income tax and regulatory
matters; the ability of Aphria to implement its business
strategies; competition; crop failure; currency and interest rate
fluctuations and other risks.
Readers are cautioned that the foregoing list is not exhaustive.
Readers are further cautioned not to place undue reliance on
forward-looking statements as there can be no assurance that the
plans, intentions or expectations upon which they are placed will
occur. Such information, although considered reasonable by
management at the time of preparation, may prove to be incorrect
and actual results may differ materially from those
anticipated.
The forward-looking statements included in this news release are
made as of the date of this news release and the Company does not
undertake an obligation to publicly update such forward-looking
statements to reflect new information, subsequent events or
otherwise unless required by applicable securities laws.
Forward-looking statements contained in this news release are
expressly qualified by this cautionary statement.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/aphria-introduces-cannrelief-a-cbd-based-nutraceutical-and-cosmetics-product-line-for-the-german-market-300821577.html
SOURCE Aphria Inc.